Related Experiment Videos
The metabolic effects of caffeine in the newborn infant
Insights
Caffeine citrate reduced apnea in premature infants but affected glucose levels differently based on feeding method. Intravenous dextrose maintained glucose, while formula feeding led to a significant drop.
Area of Science:
- Neonatal Medicine
- Pharmacology
- Pediatric Physiology
Background:
- Premature infants often experience recurrent apnea, a common respiratory challenge.
- Caffeine citrate is a standard treatment for apnea of prematurity.
- Understanding caffeine's metabolic and physiological effects is crucial for optimizing infant care.
Purpose of the Study:
- To investigate the impact of caffeine citrate on glucose homeostasis in premature infants.
- To assess caffeine's effects on cardiorespiratory status and catecholamine/electrolyte excretion.
- To determine if feeding methods influence caffeine's metabolic effects.
Main Methods:
- Intravenous caffeine citrate (20 mg/kg) administered to 12 premature infants with recurrent apnea.
- Two feeding groups: intravenous dextrose (n=6) and formula feeding (n=6).
- Plasma glucose monitored pre- and post-caffeine; cardiorespiratory status and urinary markers assessed over 12 hours.
Main Results:
- Caffeine citrate significantly reduced apneic episodes.
- Intravenously fed infants maintained stable plasma glucose levels post-caffeine.
- Formula-fed infants exhibited a significant decrease in plasma glucose after caffeine administration.
- No significant changes observed in heart rate or urinary excretion of sodium, potassium, epinephrine, norepinephrine, or dopamine.
Conclusions:
- Caffeine citrate effectively manages apnea in premature infants.
- The route and type of substrate administration significantly influence caffeine's effect on glucose homeostasis.
- Findings highlight the importance of considering feeding strategies alongside caffeine therapy in neonates.
Abstract:
We studied the effects of intravenous administration of 20 mg/kg caffeine citrate on glucose homeostasis, cardiorespiratory status, and urinary excretion of catecholamines and electrolytes in 12 premature infants with recurrent apnea. Six infants received intravenous dextrose (5% or 10% in 0.225% saline) during the study, and six were fed formula every 3-4 hours. In the intravenously fed infants, the plasma glucose concentration postcaffeine did not vary significantly from the precaffeine level of 73 +/- 3.2 mg/dl (mean +/- SEM) at 0.5, 1, and 1.5 hours. However, in the formula-fed infants, there was a consistent fall in plasma glucose levels after caffeine administration. This decrease from a precaffeine level of 99 +/- 12 mg/dl (mean +/- SEM) approached statistical significance at 0.5 hours (P = 0.07), and was significantly lower at 1 and 1.5 hours (P less than 0.02). In five infants, cardiorespiratory status and urinary excretion of catecholamines and electrolytes were evaluated for 12-hour periods before and after caffeine administration. There was a significant reduction in the number of apneic episodes following caffeine administration; however, caffeine did not appear to affect mean heart rate or urinary excretion of sodium, potassium, epinephrine, norepinephrine, or dopamine. Our data suggest that the effects of caffeine on glucose homeostasis may vary with the nature and/or route of substrate administration.